纳斯达克 · 医疗分销 · USD
Cosmos Health Inc. (COSM) 股票分析
Cosmos Health Inc.（COSM）是在纳斯达克上市的医疗分销股票，以美元交易。
最后更新: 2026年10月21日
价格走势
暂无价格数据
悬停查看每日收盘价。虚线表示区间起始价。
COSM 关键统计数据
数据截至2026年10月21日交易
- 开盘价
- $0.33
- 前收盘价
- $0.33
- 当日波动区间
- 0.27–0.33
- 52周波动区间
- 0.16–1.07
- 成交量
- 284.36万
- Beta系数股价相对大盘的波动幅度。1.0与大盘同步，高于1.0波动更大，低于1.0更小。
- 4.21
估值
- 市值
- $2824.79万
- 市盈率
- 亏损
- 预期市盈率股价除以未来一年的预测盈利，而非过去一年的实际盈利。
- 4.01
- 市销率市值除以年营业收入。适用于尚未盈利、无法计算市盈率的公司。
- 0.38
- 每股收益（近12个月）过去十二个月归属于每股的利润。
- −0.65
财务（财年）
- 营业收入（财年）
- $6527.18万+19.93%
- 净利润（财年）
- −$1914.50万
- 净利率扣除全部成本和税费后，营业收入中作为利润留存的比例。
- −33.08%
- 流通股数
- 1.01亿
- 一年回报率
- −73.27%
股息与日期
- 平均成交量
- 334.23万
仅显示公司披露的指标。 数据由Yahoo Finance通过yfinance提供。每日更新。
关键数据
截至2026年10月21日，COSM收盘价为$0.28，1年回报率为−73.27%。
Cosmos Health Inc.（COSM）的市值为$2824.79万。
2025财年，COSM的营业收入为$6527.18万。
COSM 历年回报率
Cosmos Health Inc.（COSM）10年回报：$10,000变成了多少
- 1年
- $10,000 $2,673
- −73.27%
- 5年
- $10,000 $661
- −93.39%
- 10年
- $10,000 $458
- −95.42%
如果在10年前，即2016年10月21日收盘时，向Cosmos Health Inc.（COSM）投资$10,000，按2026年10月21日收盘价计算将变为$458：累计−95.42%，年化−26.54%。基于经拆股和股息调整的收盘价进行的历史测算，未计入费用和税费。
历年回报率根据每日收盘价计算。 不完整年度以浅色显示并标有星号。
+131.82%−69.08%−43.63%
2016*2017201820192020202120222023202420252026*
| 年份 | 回报率 |
|---|---|
| 2026 (不完整年度) | −43.63% |
| 2025 | −25.56% |
| 2024 | −52.55% |
| 2023 | −69.08% |
| 2022 | +35.31% |
| 2021 | −33.92% |
| 2020 | +131.82% |
| 2019 | −45.00% |
| 2018 | −60.78% |
| 2017 | +24.39% |
| 2016 (不完整年度) | +17.14% |
数据截至2026年10月21日。
COSM 各财年营收与利润
财年截至十二月营业收入净利润
2022202320242025
| 财年 | 营业收入 | 净利润 | 净利率 |
|---|---|---|---|
| 2025 | $6527.18万 | −$1914.50万 | −29.3% |
| 2024 | $5442.64万 | −$1618.30万 | −29.7% |
| 2023 | $5337.69万 | −$1854.27万 | −34.7% |
| 2022 | $5034.77万 | −$1383.04万 | −27.5% |
| 财年 | 营业收入 | 毛利 | 营业利润 | 净利润 | 净利率 |
|---|---|---|---|---|---|
| 2025 | $6527.18万 | $789.56万 | −$1654.08万 | −$1914.50万 | −29.3% |
| 2024 | $5442.64万 | $431.13万 | −$1525.29万 | −$1618.30万 | −29.7% |
| 2023 | $5337.69万 | $434.96万 | −$2183.12万 | −$1854.27万 | −34.7% |
| 2022 | $5034.77万 | $595.70万 | −$747.40万 | −$1383.04万 | −27.5% |
为公司报告货币口径的年度公布数据。 数据截至2025年12月31日。
COSM估值与医疗分销中位数对比
11只股票的中位数| 指标 | COSM | 医疗分销中位数 | 相对中位数 |
|---|---|---|---|
| 市销率 | 0.38 | 0.38 | 高0% |
| 净利率 | −33.08% | −4.73% | 低28.4个百分点 |
基于11只披露该指标的医疗分销股票的中位数。采用中位数而非平均值，异常值不会扭曲结果。 数据截至2026年10月21日。
最新新闻
Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days
YahooCosmos Health Expects Q4 Sales Of ~$15M, Gross Profit Of ~$10.5M With Gross Margin Of ~70%
BenzingaCosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription
YahooCOSM US Growth Impresses
YahooCosmos Health Reaches 6,287 Active U.S. Subscriptions Generating ~$920K In Monthly Renewal Value; 60.5% Of Online Orders Include Subscriptions, Rising To More Than 75% In Recent Days As Adoption Accelerates
BenzingaCosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days
Yahoo
全部20篇文章 ↓收起 ↑
Cosmos Health Record One-Day U.S. Direct-To-Consumer Sales Of $92K+ On October 11 And $902K In 30 Days
BenzingaCosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million
YahooCOSM Continues to Surge Revenue Growth
YahooCosmos Health Sees Q3 Sales $17.400M vs $20.886M Est
BenzingaCosmos Health FY2026 Revenue expected to be more than $90.000M vs $84.300M Est
BenzingaCosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion
YahooCOSM Continues to Grow Business
YahooCosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue
YahooCosmos Health’s CosmoFarm Reports Q2 Revenue Of Over $15M, $60M Annualized Run Rate; Says Robotics, Automation And AI-Enabled Systems Across Procurement, Inventory And Order Execution, With Capacity That Could Support A Further $40M Or More In Annual Revenue, Which Would Provide Infrastructure For Annualized Revenue Above $100M
BenzingaCosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
YahooCosmos Health's Cana Laboratories Subsidiary Achieves Over $20M In Revenue
BenzingaCosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June
YahooCosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market
YahooCosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
Yahoo
新闻由第三方来源提供。不构成投资建议。
分析
数据生成以上所有数字均在每日重新生成时从本页自身的数据中读取。仅供参考，不构成投资建议。 数据截至2026年10月21日。
相关医疗分销股票
MCK
查看所有医疗分销股票 →
McKesson Corporation
$1183.98亿
CORCencora, Inc.
$649.63亿
CAHCardinal Health, Inc.
$588.30亿
HSICHenry Schein, Inc.
$94.74亿
AHGAkso Health Group
$10.88亿
FOCLEDAP TMS S.A.
$2.06亿
医疗保健热门股票
LLY
查看所有医疗保健股票 →
Eli Lilly and Company
$1.13万亿
JNJJohnson & Johnson
$6212.24亿
ABBVAbbVie Inc.
$5032.75亿
UNHUnitedHealth Group Incorporated
$3742.97亿
MRKMerck & Co., Inc.
$3697.80亿